### **CRSP03 - CRISPR Therapeutics Ltd (CRSP)**

**CRISPR Therapeutics Ltd (CRSP)**  is a biotechnology company focused on developing transformative therapies for genetic diseases using CRISPR/Cas9 gene-editing technology.

The company’s research and development efforts span multiple disease areas, utilizing both ex vivo and in vivo gene-editing approaches. CRISPR Therapeutics’ core strengths lie in its strong intellectual property portfolio and deep scientific expertise, which support long-term innovation and the advancement of next-generation therapeutic solutions.

#### **Additional Details**

<style>
        #table {
            width: 100%;
            border-collapse: collapse;
            font-family: Arial, sans-serif;
        }

        #table th, #table td {
            border: 1px solid #ddd;
            padding: 8px;
            text-align: left;
            color: #222; /* Darker Font */
        }

        #table th {
            background-color: #D9D9D9; /* Light Grey */
            color: #111; /* Very Dark Text for Header */
            font-weight: bold;
        }

        #table tr:nth-child(even) {
            background-color: #F4F4F4; /* Very Light Grey */
        }

        #table tr:nth-child(odd) {
            background-color: #FFFFFF; /* White */
        }

        #table a {
            color: #000; /* Black for Links */
            text-decoration: none;
            font-weight: bold;
        }

        #table a:hover {
            text-decoration: underline;
        }
</style>

<table id="table">
    <tr>
        <th>Issuer</th>
        <td>Pi Securities Public Company Limited</td>
    </tr>
    <tr>
        <th>DR Symbol</th>
        <td>CRSP03</td>
    </tr>
    <tr>
        <th>DR Reference Ratio</th>
        <td>500 DR : 1 UL</td>
    </tr>
    <tr>
        <th>Underlying Security</th>
        <td>CRISPR Therapeutics Ltd (CRSP)</td>
    </tr>
    <tr>
        <th>Type of Underlying Security</th>
        <td>Common Stock</td>
    </tr>
    <tr>
        <th>Exchange of Underlying Security</th>
        <td>U.S. Equities Exchanges</td>
    </tr>
    <tr>
        <th>Reference Asset Issuer’s Website</th>
        <td><a href="https://crisprtx.com/" target="_blank"> CRISPR Website</a></td>
    </tr>
</table>

CRSP03 – CRISPR Therapeutics Ltd (CRSP) - Revolutionizing disease treatment through next-generation gene editing technology

CRSP03 - CRISPR Therapeutics Ltd (CRSP)

Additional Details

CRSP03 - CRISPR Therapeutics Ltd (CRSP)

DR Price